BioGaia AB ser. B (BIOGBs)

Currency in SEK
95.63
0.00(0.00%)
Delayed Data·
BIOGBs Scorecard
Full Analysis
Trading at a high earnings multiple
High dividend Yield
BIOGBs is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
95.6395.63
52 wk Range
95.62126.15
Key Statistics
Bid/Ask
115.00 / 114.80
Prev. Close
95.63
Open
95.63
Day's Range
95.63-95.63
52 wk Range
95.62-126.15
Volume
-
Average Volume (3m)
2.59K
1-Year Change
-25.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOGBs Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

BioGaia AB ser. B Company Profile

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.

Employees
230
Market
Sweden

Compare BIOGBs to Peers and Sector

Metrics to compare
BIOGBs
Peers
Sector
Relationship
P/E Ratio
33.5x0.1x−0.5x
PEG Ratio
−1.11−0.840.00
Price/Book
8.3x7.2x2.6x
Price / LTM Sales
6.7x36.7x3.3x
Upside (Analyst Target)
-5.7%43.5%
Fair Value Upside
Unlock17.9%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.83%
Dividend Yield
6.90%
Industry Median 2.49%
Annualised payout
6.90
Paid unevenly
5-Years Growth
+21.06%
Growth Streak

Earnings

Latest Release
Jul 18, 2025
EPS / Forecast
0.87 / 0.9267
Revenue / Forecast
405.00M / 391.30M
EPS Revisions
Last 90 days

BIOGBs Income Statement

People Also Watch

41.855
ITX
+1.15%
265.80
SWEDa
+0.95%
62.550
ANDR
+2.21%
86.70
NEDP
+1.76%
827.00
ROBF
+0.85%

FAQ

What Stock Exchange Does BioGaia AB ser. B Trade On?

BioGaia AB ser. B is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for BioGaia AB ser. B?

The stock symbol for BioGaia AB ser. B is "BIOGBs."

What Is the BioGaia AB ser. B Market Cap?

As of today, BioGaia AB ser. B market cap is 9.62B.

What Is BioGaia AB ser. B's Earnings Per Share (TTM)?

The BioGaia AB ser. B EPS (TTM) is 2.83.

When Is the Next BioGaia AB ser. B Earnings Date?

BioGaia AB ser. B will release its next earnings report on 21 Oct 2025.

From a Technical Analysis Perspective, Is BIOGBs a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioGaia AB ser. B Stock Split?

BioGaia AB ser. B has split 1 times.

How Many Employees Does BioGaia AB ser. B Have?

BioGaia AB ser. B has 230 employees.

What is the current trading status of BioGaia AB ser. B (BIOGBs)?

As of 07 Aug 2025, BioGaia AB ser. B (BIOGBs) is trading at a price of 95.63, with a previous close of 95.63. The stock has fluctuated within a day range of 95.63 to 95.63, while its 52-week range spans from 95.62 to 126.15.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.